Catalyst Wire Dossier Catalyst Wire Dossier

ALLN-177

· Allena Pharmaceuticals
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for ALLN-177, covering 2016-04-27 to 2020-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia [Phase 2]

See pricing